Anogenital cancers testing in Fossato di Vico

Find health labs to test for Anogenital cancers in Fossato di Vico and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Delta Implants

Via Pietro Cestellini, 11, 06135 Perugia PG, Italia

22.8 km

Unverified

A Pap Smear costs €140.00

See Details

Pap Smear by Galeno Srl - Laboratorio Analisi Cliniche

Via Martiri dei Lager, 7, 06128 Perugia PG, Italia

22.8 km

Unverified

See Details

Pap Smear by PROTOS Centro Diagnostico

Via del Discobolo, 14, 06132 Perugia PG, Italia

22.8 km

Unverified

A Pap Smear costs €140.00

See Details

Pap Test by La Quintana - Centro Medico

Via Giovanni Polanga, 1, 06034 Foligno PG, Italia

23.6 km

Unverified

A Pap Smear costs €140.00

See Details

Pap Smear by Crabion S.R.L.

Via Amilcare Ponchielli, 8, 06073 Corciano PG, Italia

26.5 km

Unverified

See Details

Pap Smear by Galeno Srl - Laboratorio Analisi Cliniche

Via Piero della Francesca, 34, 06012 Città di Castello PG, Italia

28.6 km

Unverified

See Details

Pap Smear by Synlab

Terontola Alta, 67, 52044 Cortona AR, Italia

39.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Marco Polo, 21 60027 Osimo (AN)

38.5 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Ottorino Respighi, 54 61122 Pesaro (PU)

43.2 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Della Madonna del Rivaio, 84 c/o Misericordia di Castiglion Fiorentino 52043 Castiglion Fiorentino (AR)

42.2 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.